26 results
Thumbnail

D3.344 - Biological therapy for severe chronic spontaneous urticaria associated with autoimmune atrophic gastritis

Thumbnail

D3.348 - A Case of 19p13.3 Microdeletion

Thumbnail

D3.349 - Evaluation of natural killer cells in female infertility

Thumbnail

D3.351 - Characterization of peanut roasting-enhanced Ara h 2 - Ara h 1 complexes

Thumbnail

D3.345 - Blood Dendritic Cell Antigen 3-Positive Dendritic Cells Attenuate Th2 Responses in Allergic Rhinitis and Chronic Rhinosinusitis

Thumbnail

D3.346 - Impact of local craniocerebral hypothermia on inflammatory cytokine production in ischemic stroke

Thumbnail

D3.347 - AllergoOncology: a systematic review of the impact of glycosylation on IgE antibody structure function and mechanisms of disease

Thumbnail

D3.350 - Monocytic myeloid-derived suppressor cells (M-MDSCs) increase the expression of TIGIT on γδ T cells

Thumbnail

D3.353 - An EAACI Task Force Scoping Review: Human Monocytes and Macrophages in Allergy – Implications for AllergoOncology

Thumbnail

D3.354 - Selective IgE deficiency in children: its role in autoimmunity

Thumbnail

D3.355 - Decoupling of total IgE and peripheral blood eosinophilia in pancreatic ductal adenocarcinoma: preliminary study

Thumbnail

D3.356 - Unconventional T cells in leukocyte adhesion deficiency I (LAD-I)

Thumbnail

D2.167 - Effect of Metformin on allergen specific immunotherapy

Thumbnail

D2.169 - Association of Antenatal Corticosteroid Treatment with Risk of Allergic Diseases in Children

Thumbnail

D2.174 - Patient survey to determine the minimal clinically important difference for a combined symptom and medication score in grass AIT

Thumbnail

D2.179 - Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study

Thumbnail

D2.168 - Systemic reactions to subcutaneous immunotherapy in children

Thumbnail

D2.170 - The placebo effect leads to significantly lower values regarding allergic symptoms and medication use in birch-pollen allergic patients during the birch pollen season

Thumbnail

D2.171 - The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment

Thumbnail

D2.172 - Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions